Preoperative plasma amyloid-β oligomers (MDS-OAβ) have emerged as a promising biomarker for identifying older surgical patients at risk for postoperative delirium (POD). A study involving 101 patients aged 65 and older undergoing elective orthopedic surgery found that higher preoperative MDS-OAβ concentrations correlated with the development and severity of delirium, with an impressive area under the curve (AUC) of 0.855 for delirium discrimination.

The findings underscore the potential significance of MDS-OAβ in clinical settings, where the ability to stratify patients based on their neurodegenerative vulnerability could enhance perioperative care. The study demonstrated that a dual-threshold approach using MDS-OAβ can effectively categorize patients into low-risk and high-risk groups, with high negative predictive values for the former and high positive predictive values for the latter. This stratification allows for targeted interventions and closer monitoring of intermediate-risk patients, which could mitigate the incidence and severity of POD.

The implications of this research are substantial for the field of aging biology and clinical practice. By integrating MDS-OAβ as a biomarker for risk stratification, clinicians can refine their approach to delirium prevention and management in older adults. This biomarker-guided strategy not only complements existing delirium surveillance protocols but also paves the way for future studies aimed at developing tailored therapeutic interventions that could improve healthspan and surgical outcomes in this vulnerable population.

Source: academic.oup.com